4.4 Article

A Manganese Phosphate Nanocluster Activates the cGAS-STING Pathway for Enhanced Cancer Immunotherapy

相关参考文献

注意:仅列出部分参考文献,下载原文获取全部文献信息。
Article Engineering, Biomedical

In situ activation of STING pathway with polymeric SN38 for cancer chemoimmunotherapy

Jiayu Zhao et al.

Summary: The study presented a method for in situ activation of the STING pathway using nanoparticles to deliver DNA-targeting chemo agents, demonstrating the potent ability of SN38 in stimulating interferon secretion and activating the STING pathway. The nanoparticle formulation effectively stimulated STING pathway activation, resulting in significant tumor suppression.

BIOMATERIALS (2021)

Article Chemistry, Multidisciplinary

Maintaining manganese in tumor to activate cGAS-STING pathway evokes a robust abscopal anti-tumor effect

Chao Wang et al.

Summary: Synchronizing Mn2+ delivery with accumulated cytosolic DNA after radiotherapy can promote the activation of the cGAS-STING pathway and enhance antitumor immunity. This strategy can achieve over 90% inhibition rate even in unirradiated tumors, providing a simple and novel approach to effectively activate the immune response in tumors.

JOURNAL OF CONTROLLED RELEASE (2021)

Article Immunology

Manganese-Doped Silica-Based Nanoparticles Promote the Efficacy of Antigen-Specific Immunotherapy

Janin Chandra et al.

Summary: This study demonstrates the development of a nanomaterial-based therapeutic HPV vaccine that activates the inflammatory signaling pathway and promotes immune cell recruitment and dendritic cell maturation, leading to strong E7-specific CD8(+) T cell responses in mice. The vaccine shows potential for remission of established HPV-associated tumors and showcases a simple and general strategy for therapeutic HPV and other cancer vaccines.

JOURNAL OF IMMUNOLOGY (2021)

Article Multidisciplinary Sciences

Tumor-specific cytolytic CD4 T cells mediate immunity against human cancer

Amelie Cachot et al.

Summary: CD4 T cells displaying cytotoxic phenotypes were identified in different human cancers through mining single-cell RNA-seq datasets. Ex vivo confirmation of the cytolytic tumor-specific CD4 T cells was achieved using peptide-MHCII-multimer technology. The cytotoxic activity of these cells, partially dependent on SLAMF7, was demonstrated to have delayed kinetics compared to classical cytotoxic lymphocytes, and agonistic engagement of SLAMF7 enhanced their cytotoxicity, indicating potential synergy with other cancer immunotherapies.

SCIENCE ADVANCES (2021)

Article Materials Science, Biomaterials

The lipid platform increases the activity of STING agonists to synergize checkpoint blockade therapy against melanoma

Kesang Li et al.

Summary: In this study, the targeted delivery of cGAMP using LP-cGAMP was found to enhance DC maturation and CD8(+) T cell infiltration, leading to a superior antitumor effect in melanoma models when combined with anti-PD-L1 therapy. This demonstrates the great potential of combinational immune therapy for producing a long-lasting anti-tumor effect.

BIOMATERIALS SCIENCE (2021)

Article Immunology

Tumor-Derived cGAMP Regulates Activation of the Vasculature

Marco Campisi et al.

FRONTIERS IN IMMUNOLOGY (2020)

Review Medicine, General & Internal

Challenges and Opportunities in the Clinical Development of STING Agonists for Cancer Immunotherapy

Leila Motedayen Aval et al.

JOURNAL OF CLINICAL MEDICINE (2020)

Article Pharmacology & Pharmacy

pH-Responsive STING-Activating DNA Nanovaccines for Cancer Immunotherapy

Yu Zhang et al.

ADVANCED THERAPEUTICS (2020)

Article Multidisciplinary Sciences

An orally available non-nucleotide STING agonist with antitumor activity

Bo-Sheng Pan et al.

SCIENCE (2020)

Review Multidisciplinary Sciences

cGAS in action: Expanding roles in immunity and inflammation

Andrea Ablasser et al.

SCIENCE (2019)

Article Pharmacology & Pharmacy

Dual delivery of nucleic acids and PEGylated-bisphosphonates via calcium phosphate nanoparticles

Sofia Bisso et al.

EUROPEAN JOURNAL OF PHARMACEUTICS AND BIOPHARMACEUTICS (2019)

Article Nanoscience & Nanotechnology

Biodegradable STING agonist nanoparticles for enhanced cancer immunotherapy

David R. Wilson et al.

NANOMEDICINE-NANOTECHNOLOGY BIOLOGY AND MEDICINE (2018)

Review Cell Biology

The Essential Element Manganese, Oxidative Stress, and Metabolic Diseases: Links and Interactions

Longman Li et al.

OXIDATIVE MEDICINE AND CELLULAR LONGEVITY (2018)

Article Biochemistry & Molecular Biology

RINCK-mediated monoubiquitination of cGAS promotes antiviral innate immune responses

Zhao-Shan Liu et al.

CELL AND BIOSCIENCE (2018)

Review Oncology

Metabolic reprogramming of mitochondrial respiration in metastatic cancer

P. M. Herst et al.

CANCER AND METASTASIS REVIEWS (2018)

Article Nanoscience & Nanotechnology

A STING-activating nanovaccine for cancer immunotherapy

Min Luo et al.

NATURE NANOTECHNOLOGY (2017)

Article Materials Science, Biomaterials

Liposomal Delivery Enhances Immune Activation by STING Agonists for Cancer Immunotherapy

Sandeep T. Koshy et al.

ADVANCED BIOSYSTEMS (2017)

Article Chemistry, Multidisciplinary

Liposomes loaded with a STING pathway ligand, cyclic di-GMP, enhance cancer immunotherapy against metastatic melanoma

Takashi Nakamura et al.

JOURNAL OF CONTROLLED RELEASE (2015)

Article Multidisciplinary Sciences

STING activation of tumor endothelial cells initiates spontaneous and therapeutic antitumor immunity

Olivier Demaria et al.

PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2015)

Review Biochemistry & Molecular Biology

The cGAS-cGAMP-STING Pathway of Cytosolic DNA Sensing and Signaling

Xin Cai et al.

MOLECULAR CELL (2014)

Article Immunology

Bacterial c-di-GMP is an immunostimulatory molecule

David K. R. Karaolis et al.

JOURNAL OF IMMUNOLOGY (2007)

Review Medicine, General & Internal

Phosphorus nutrition and the treatment of osteoporosis

RP Heaney

MAYO CLINIC PROCEEDINGS (2004)

Article Pharmacology & Pharmacy

Calcium phosphate nanoparticles as novel non-viral vectors for targeted gene delivery

I Roy et al.

INTERNATIONAL JOURNAL OF PHARMACEUTICS (2003)